Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response
Clinical Trial Phase I/II, of Test of Concept, Blind Double, Randomized, Controlled With Placebo, to Assess the Safety and Efficiency of the Treatment With Allogenic Adult Mesenchymal Stem Cells From Adipose Tissue Expanded, in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response
Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
This PHASE1/PHASE2 trial investigates Discordant Immunological Response in HIV Infected Subjects and is currently completed. Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Feb 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Unknown Status → Active Not Recruiting
-
May 2017 — Apr 2018 [monthly]
Unknown Status PHASE1_PHASE2
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- Iniciativa Andaluza en Terapias Avanzadas
For direct contact, visit the study record on ClinicalTrials.gov .